Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$809K Hold
2,300
0.16% 43
2025
Q4
$753K Hold
2,300
0.15% 41
2025
Q3
$649K Hold
2,300
0.14% 45
2025
Q2
$642K Hold
2,300
0.15% 43
2025
Q1
$717K Hold
2,300
0.19% 40
2024
Q4
$599K Hold
2,300
0.15% 45
2024
Q3
$741K Hold
2,300
0.17% 40
2024
Q2
$719K Hold
2,300
0.19% 39
2024
Q1
$654K Sell
2,300
-1
-0% -$293 0.18% 41
2023
Q4
$663K Buy
2,301
+1
+0% +$272 0.2% 39
2023
Q3
$618K Hold
2,300
0.22% 41
2023
Q2
$511K Sell
2,300
-3
-0.1% -$696 0.18% 44
2023
Q1
$557K Sell
2,303
-1
-0% -$245 0.21% 42
2022
Q4
$605K Sell
2,304
-68
-3% -$18.2K 0.28% 43
2022
Q3
$535K Hold
2,372
0.28% 40
2022
Q2
$577K Hold
2,372
0.3% 37
2022
Q1
$574K Buy
2,372
+1
+0% +$230 0.32% 39
2021
Q4
$533K Buy
+2,371
New +$500K 0.29% 41

Other funds holding AMGN

RS Crum Inc's AMGN Position: Q1 2026 in Review

RS Crum Inc held its Amgen (AMGN) position steady in Q1 2026 at 2,300 shares worth $809K. The position accounts for 0.16% of the portfolio, ranked #43.

RS Crum Inc first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • RS Crum Inc held 2,300 shares of Amgen worth $809K as of Q1 2026.
  • RS Crum Inc left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.16% of RS Crum Inc's portfolio in Q1 2026, its #43 holding.
  • RS Crum Inc first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on RS Crum Inc's 13F filing for Q1 2026, filed 15 Apr 2026.